Towards the end of last year, Mike Tyson took on Ray Jones Jr. in a boxing match for the first time in more than a decade. In a pay-per-view exhibition, the two boxed, ending the eight-round fight 78 to 74 for Tyson.
During an interview with Reuters, Mike Tyson, commonly known as Iron Mike, revealed that he had struggled with drug addiction in his life, asserting that the use of psilocybin helped him get back on his feet. He explained that once he was introduced to psilocybin mushrooms, his whole life changed, adding that the shrooms had helped him when he was suicidal. He asserted that psychedelics were amazing as therapeutics and noted that people should look at them from that perspective.
In the interview, Tyson revealed that he wanted to share his experience with the world, having recently joined a life sciences firm known as Wesana Health to help spread the message on psychedelics and their healing potential.
Wesana Health was founded by Daniel Carcillo, a former NHL player. Similar to Tyson, Carcillo had struggled with suicidal ideation and depression after he retired from hockey. However, after a psilocybin therapy session with Riley Cote, who is also a former NHL player, Carcillo stated that his life changed. In an interview conducted last year with the GrowthOp, Carcillo explained that Riley had helped save his life.
Earlier in May, Wesana announced that it would be conducting a clinical research project in collaboration with the World Boxing Council to discover new treatments for traumatic brain injuries. The project will also entail further study of the company’s psilocybin formulation dubbed Sana0013, which may be a possible treatment for traumatic brain injuries.
During his career in the NHL as an enforcer, Carcillo experienced many concussions, seven of which were diagnosed. In the interview, he asserted that psilocybin had cured him of traumatic brain injury and its associated symptoms. He explained that after his therapeutic sessions with psilocybin, he no longer suffered from suicidal ideation, depression, anxiety, impulse control issues, insomnia, head pressure, headaches or slurred speech.
Tyson, who has also seen improvements in his overall health after undergoing therapeutic sessions with magic mushrooms, believes that stories such as his and Carcillo’s should be shared. While concluding his interview with Reuters, Tyson noted that he believed psychedelics were good for the world, adding that instead of conducting small ceremonies, which made the substances’ access very limited, they needed to be made accessible to everyone.
Personal testimonies aside, rigorous research is being done by a number of companies, including Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF); that research is aimed at developing functional as well as medicinal products from psychedelics.
NOTE TO INVESTORS: The latest news and updates relating to Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) are available in the company’s newsroom at https://ibn.fm/PULL
About PsychedelicNewsWire
PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.
To receive instant SMS alerts, text “Groovy” to 888-902-4192 (U.S. Mobile Phones Only)
For more information please visit https://www.psychedelicnewswire.com
Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.psychedelicnewswire.com/Disclaimer
Do you have questions or are you interested in working with PNW? Ask our Editor
PsychedelicNewsWire (PNW)
San Francisco, California
www.psychedelicnewswire.com
415.949.5050 Office
Editor@PsychedelicWire.com
PsychedelicNewsWire is part of the InvestorBrandNetwork.
